FMCA (Bukwang)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameFMCA (Bukwang)
Drug Alias Namechronic HBV infection therapy (Bukwang)chronic HBV infection therapy (University of Georgia)FMCASNC-019754
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Georgia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBukwang Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A